Nicolas Duployez
Overview
Explore the profile of Nicolas Duployez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
114
Citations
1240
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Oligomonocytic chronic myelomonocytic leukemia is eligible to MDS-score and not Mono-dysplasia score
Podvin B, Magierowicz M, Soenen V, Dumezy F, Duployez N, Charpentier A
Int J Lab Hematol
. 2024 Apr;
46(5):969-970.
PMID: 38644333
No abstract available.
12.
Mahevas T, Osio A, Larcher L, Clappier E, Kempf W, Ades L, et al.
Blood Adv
. 2024 Apr;
8(12):3293-3298.
PMID: 38621250
No abstract available.
13.
Groh M, Fenwarth L, Labro M, Boudry A, Fournier E, Wemeau M, et al.
Am J Hematol
. 2024 Apr;
99(6):1108-1118.
PMID: 38563187
We investigated using a custom NGS panel of 149 genes the mutational landscape of 64 consecutive adult patients with tyrosine kinase fusion-negative hypereosinophilia (HE)/hypereosinophilic syndrome (HES) harboring features suggestive of...
14.
Genomic imbalance analysis provides new insight into prognostic factors in adult and pediatric T-ALL
Balducci E, Simonin M, Duployez N, Steimle T, Dourthe M, Villarese P, et al.
Blood
. 2024 Mar;
144(9):988-1000.
PMID: 38518104
Given the poor outcome of refractory and relapsing T-cell acute lymphoblastic leukemia (T-ALL), identifying prognostic markers is still challenging. Using single nucleotide polymorphism (SNP) array analysis, we provide a comprehensive...
15.
Flechon L, Arib I, Dutta A, Hasan Bou Issa L, Sklavenitis-Pistofidis R, Tilmont R, et al.
Blood Adv
. 2024 Mar;
8(12):3109-3119.
PMID: 38513135
Mycosis fungoides (MF) is the most prevalent primary cutaneous T-cell lymphoma, with an indolent or aggressive course and poor survival. The pathogenesis of MF remains unclear, and prognostic factors in...
16.
Ducassou S, Abou Chahla W, Duployez N, Halfon-Domenech C, Brethon B, Poiree M, et al.
Bull Cancer
. 2024 Mar;
111(5):513-524.
PMID: 38503585
Neonatal acute myeloid leukemias (AML) occurred within the first 28 days of life and constitute only a small proportion of all AL. They are distinguished from leukemias of older children...
17.
Freiman L, Larcher L, Tueur G, Vasquez N, Da Costa M, Duchmann M, et al.
Leukemia
. 2024 Feb;
38(4):908-911.
PMID: 38378842
No abstract available.
18.
Sebert M, Freiman L, Chaffaut C, Guerci A, Peterlin P, Thepot S, et al.
Leukemia
. 2024 Feb;
38(4):918-922.
PMID: 38368440
No abstract available.
19.
Yang M, Gunnarsson R, Duployez N, Zaliova M, Zuna J, Johansson B, et al.
Haematologica
. 2024 Feb;
109(6):1951-1955.
PMID: 38356456
No abstract available.
20.
Strullu M, Cousin E, Montgolfier S, Fenwarth L, Gachard N, Arnoux I, et al.
Bull Cancer
. 2024 Jan;
111(3):291-309.
PMID: 38267311
The spectrum of childhood leukemia predisposition syndromes has grown significantly over last decades. These predisposition syndromes mainly involve CEBPA, ETV6, GATA2, IKZF1, PAX5, RUNX1, SAMD9/SAMD9L, TP53, RAS-MAPK pathway, DNA mismatch...